In our subset analysis in patients with brain metastases, RFL response at 24 h after the first dose of MNTX was similar but, with an RFL response differential of 20.4%, did not reach statistical significance compared with the placebo group.
← all excerpts
The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies.
1
—
—